Navigation Links
Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal
Date:9/17/2008

ge or any of its provisions will be left to the determination of each party acting independently."

Under the Department's business review procedure, an organization may submit a proposed action to the Antitrust Division and receive a statement as to whether the Division currently intends to challenge the action under the antitrust laws.

A file containing the business review request and the Department's response may be examined in the Antitrust Documents Group of the Antitrust Division, U.S. Department of Justice, 450 Fifth Street, NW, Suite 1010, Washington, D.C. 20530. After a 30-day waiting period, the documents supporting the business review will be added to the file, unless a basis for their exclusion for reasons of confidentiality has been established under the Business Review Procedure.


'/>"/>
SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. DuPont Provides Technology for Washington Hospital Centers Emergency Department
5. NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters
6. PA Department of Health Reports Rise in Flu Activity; Reminds Public of Need for Flu Shot
7. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
8. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
9. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
10. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
11. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... ZURICH, Ill., Dec. 15 Fenwal Inc., a ... availability for patient care, reiterated its commitment to provide ... lifesaving blood products, despite a new lawsuit filed yesterday ... Fenwal® Alyx® system, introduced in 2003, is an advanced ... red cells from a single donor in about 30 ...
(Date:12/15/2009)... -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... 2009 special dividend payment of $1.67 per share to ... 1, 2009. With this payment, distributions to stockholders ... per share. In January 2010, the Company will ... the Company,s 2009 cash distributions and the allocation between ...
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC ... development of advanced preclinical platforms and tumor specific ... today announced its financial results for the second ... details of Company,s financial results are available in ... ,, Total revenues for the second quarter of ...
Breaking Medicine Technology:Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 3PDL BioPharma Completes December 15 Special Dividend Payment 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 1Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 2Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 3Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 4Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 5Spots Still Available to Run 2009 ING New York City Marathon With Team Reeve 51427 1Spots Still Available to Run 2009 ING New York City Marathon With Team Reeve 51427 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3
... -, PHOENIX, Sept. 4 Zila, Inc.,s (Nasdaq: ... early detection of,abnormalities which can lead to oral cancer, ... II study of Cetuximab (ERBITUX(R)), a,leading cancer therapeutic for ... IMCL ) and distributed by Bristol-Meyers Squibb (NYSE:,BMY). ...
... Monte Carlo brings predictability to whole range ... of Phase II, III and ... Tourtellotte Solutions, a,global leader in off-the-shelf and custom supply ... today announced,the release of its tcVisualize(TM) 3.0 clinical trial ...
Other Medicine Technology:Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 2Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 3Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2
(Date:12/16/2009)... myopia now than in the ,70s, study finds , , ... more common in the United States than it was ... study shows. , Researchers compared National Health and Nutrition ... from 1971 to 1972 and from 8,339 black and ... 12 to 54 years old. , The prevalence of ...
(Date:12/16/2009)... earn a free 21-count one week trial bottle sample with purchase ... ... December 16, 2009 -- ImmuneResponse247.com announces a special ... Immune Response 247™ 6 Mushroom Formula , with the purchase ... 247™ 6 Mushroom Formula is packaged in FDA approved facilities and ...
(Date:12/16/2009)... proud to announce being presented with the Weatherhead 100 Upstart Award ... growing companies in Northeast Ohio and is a testament to hard ... , ... (PRWEB) December 16, 2009 -- Request A ... 100 Upstart Award on December 3, 2009. The Weatherhead 100 ...
(Date:12/16/2009)... the perfect gift to give that special woman who has everything? ... Esthetician Mary Schook introduces exceptional beauty products online while educating the ... ... (PRWEB) December 16, 2009 -- The holidays are rapidly ... special woman who has everything? Why stem cells, of course!, , ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected ... Care Act that would have helped make prescription ... and legal importation of lower priced drugs from ... sponsored by Senators Dorgan, Snowe, McCain, Grassley and ... bring down the skyrocketing costs of prescription drugs. ...
Breaking Medicine News(10 mins):Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3
... to the issue of self harm. Self-Harm is most often ... support, help and above all, understanding. According to a recent ... to help a person who self-harms. ,The "see ... to the fore - that nearly 41% of adults ...
... has now established that a delayed-release stimulant, used for ... with less abuse, when compared to other stimulant drugs//. ... an oral formulation have not been reported to produce ... results of the study can be found in the ...
... is a major cause of depression and Alzheimer's disease in ... which shrinks in old age resulting in depression and Alzheimer's ... develop new treatments for Alzheimer’s disease. ,The shrinkage ... cortex result in the release of high levels of stress ...
... Paris: The French government is bracing itself to tackle a ... called the Chikungunya Fever, known to be spread by mosquitoes// ... poses a risk of entering into France. ,According ... infected one fifth of La Reunion's population , and many ...
... P's and Q's, trim your hair, cut your nails, polish your ... women, no gaudy saris please //-- just some of the do's ... visit. ,Tips on how to look and what to ... prime minister and visiting dignitaries along with the special protection group ...
... has commended India for the alacrity with which the ... in the country in the last fortnight. // ... They have told us the quick response of the ... Husbandry) Upma Chowdhury informed reporters. "India's actions have added ...
Other Medicine News:Health News:Concerta, Drug Used in ADHD Treatment Less Likely To Result In Abuse 2Health News:Mind your looks for Bush visit, as world is watching 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: